Sun Pharmaceuticals reported INR25.88B in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Aspen Pharmacare APN:SJ ZAR 3.72B 1.08B
Bharat Petroleum BPCL:IN INR -1458800000 63.29B
Cipla CIPLA:IN INR 10.03B 1.14B
Dr.Reddys Laboratories DRRD:IN INR 15.92B 9.53B
Jiangsu Hengrui Me. 600276:CH CNY 1.07B 234.47M
Reliance Infra RELI:IN INR 214.94B 75.57B
Sh Fosun Pharma 600196:CH CNY 658.65M 535.96M
Sun Pharmaceuticals SUNP:IN INR 25.88B 4.37B
UPL UPLL:IN INR 21.6B 4.05B